E2

Europe Is Moving to Ban Red Yeast Rice Monacolins. Can Bergamot Fill the Gap?

Plague Never Left.

FDA Told a Promising ADC: Not Yet.

Next Year’s Flu Shot Starts Now.

Obesity Is Costing Europe Beyond the Clinic. A New Report Puts a Price on It

Cholangiocarcinoma Just Made FGFR2 Testing Harder to Ignore

From Patients to Customers: GLP-1 Marketing Is Rewriting Obesity Care

Retatrutide Isn’t Approved. Online, ‘Reta’ Is Already a Weight-Loss Brand

SMA Treatment Finally Reaches the Muscle
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
